THE Generic and Biosimilar Medicines Association has added Juno Pharmaceuticals as its newest member, with GBMA chair Allan Tillack saying the expansion is recognition of the "strength and leadership" of the organisation.
Juno ceo Mark Crotty, who is a former chair of GBMA when he was local vice president of Hospira, said joining the association was part of Juno's plan for growth.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Sep 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Sep 17
